Literature DB >> 1512605

McLeod syndrome: a distinct form of neuroacanthocytosis. Report of two cases and literature review with emphasis on neuromuscular manifestations.

T N Witt1, A Danek, M Reiter, M U Heim, J Dirschinger, E G Olsen.   

Abstract

McLeod syndrome was originally described on the basis of a specific blood group phenotype with weak expression of Kell antigens. This erythrocyte abnormality also causes acanthocytosis. The haematological findings are associated with abnormalities in other organ systems, including neuromuscular manifestations. A 51-year-old patient was followed up for 11 years. He presented with persistent muscle creatine kinase elevation and progressive heart disease and later developed a slowly progressive neuropathy and choreic movements. His younger brother presented with grand mal seizures, involuntary movements and high muscle creatine kinase when aged 43 years. Clinical myopathy was absent in both, yet muscle biopsy showed mild myopathic changes. The presence of a motor axonopathy was supported by electrophysiological findings. One brother also showed sensory axonopathy. The movement disorder suggested accompanying basal ganglia dysfunction. Earlier reports of McLeod syndrome are reviewed with respect to neuromuscular involvement. Absence of the Kx membrane protein seems to be the cause of this multi-system disorder.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1512605     DOI: 10.1007/bf00867584

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  24 in total

1.  Normal dystrophin in McLeod myopathy.

Authors:  A Danek; T N Witt; H B Stockmann; B J Weiss; D L Schotland; K H Fischbeck
Journal:  Ann Neurol       Date:  1990-11       Impact factor: 10.422

2.  Haematological changes associated with the McLeod phenotype of the Kell blood group system.

Authors:  B M Wimer; W L Marsh; H F Taswell; W R Galey
Journal:  Br J Haematol       Date:  1977-06       Impact factor: 6.998

3.  Biochemical studies on McLeod phenotype red cells and isolation of Kx antigen.

Authors:  C M Redman; W L Marsh; A Scarborough; C L Johnson; B I Rabin; M Overbeeke
Journal:  Br J Haematol       Date:  1988-01       Impact factor: 6.998

4.  Data on the distribution of fibre types in thirty-six human muscles. An autopsy study.

Authors:  M A Johnson; J Polgar; D Weightman; D Appleton
Journal:  J Neurol Sci       Date:  1973-01       Impact factor: 3.181

5.  The histographic analysis of human muscle biopsies with regard to fiber types. 1. Adult male and female.

Authors:  M H Brooke; W K Engel
Journal:  Neurology       Date:  1969-03       Impact factor: 9.910

6.  Idiopathic hyperCKemia.

Authors:  N Sunohara; A Takagi; I Nonaka; H Sugita; E Satoyoshi
Journal:  Neurology       Date:  1984-04       Impact factor: 9.910

7.  Elevated serum creatine phosphokinase in subjects with McLeod syndrome.

Authors:  W L Marsh; N J Marsh; A Moore; W A Symmans; C L Johnson; C M Redman
Journal:  Vox Sang       Date:  1981       Impact factor: 2.144

8.  Xp21 DNA microdeletion in a patient with chronic granulomatous disease, retinitis pigmentosa, and McLeod phenotype.

Authors:  G de Saint-Basile; M C Bohler; A Fischer; J Cartron; J L Dufier; C Griscelli; S H Orkin
Journal:  Hum Genet       Date:  1988-09       Impact factor: 4.132

Review 9.  Chronic granulomatous disease. Molecular genetics.

Authors:  M C Dinauer; S H Orkin
Journal:  Hematol Oncol Clin North Am       Date:  1988-06       Impact factor: 3.722

10.  Classification of the radiological morphology of the mitral valve. Differentiation between true and pseudoprolapse.

Authors:  H Spindola-Franco; L Bjork; D F Adams; H L Abrams
Journal:  Br Heart J       Date:  1980-07
View more
  6 in total

1.  Clinicopathological study of familial late infantile Hallervorden-Spatz disease: a particular form of neuroacanthocytosis.

Authors:  A Malandrini; G M Fabrizi; P Bartalucci; C Salvadori; G Berti; C Sabò; G C Guazzi
Journal:  Childs Nerv Syst       Date:  1996-03       Impact factor: 1.475

2.  Chorea-acanthocytosis: genetic linkage to chromosome 9q21.

Authors:  J P Rubio; A Danek; C Stone; R Chalmers; N Wood; C Verellen; X Ferrer; A Malandrini; G M Fabrizi; M Manfredi; J Vance; M Pericak-Vance; R Brown; G Rudolf; F Picard; E Alonso; M Brin; A H Németh; M Farrall; A P Monaco
Journal:  Am J Hum Genet       Date:  1997-10       Impact factor: 11.025

Review 3.  XK-Associated McLeod Syndrome: Nonhematological Manifestations and Relation to VPS13A Disease.

Authors:  Kevin Peikert; Andreas Hermann; Adrian Danek
Journal:  Transfus Med Hemother       Date:  2022-01-25       Impact factor: 3.747

Review 4.  Cardiac Involvement in Movement Disorders.

Authors:  Malco Rossi; Nestor Wainsztein; Marcelo Merello
Journal:  Mov Disord Clin Pract       Date:  2021-04-07

5.  Chronic granulomatous disease, the McLeod phenotype and the contiguous gene deletion syndrome-a review.

Authors:  Casey E Watkins; John Litchfield; Eunkyung Song; Gayatri B Jaishankar; Niva Misra; Nikhil Holla; Michelle Duffourc; Guha Krishnaswamy
Journal:  Clin Mol Allergy       Date:  2011-11-23

Review 6.  Untangling the Thorns: Advances in the Neuroacanthocytosis Syndromes.

Authors:  Ruth H Walker
Journal:  J Mov Disord       Date:  2015-05-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.